Fundz

Cleara Biotech Raises $2.5 Million In Seed Financing To Advance Foxo4-Therapeutics Pipeline For Treating Cancer And Chronic Diseases

PRIVATESep 28, 2022

Amount Raised

$2.5 Million

Round Type

Seed

UtrechtBiotechnologyHealth CareTherapeutics

Description

CLEARA Biotech B.V. (“Cleara” or the “Company”), a preclinical-stage biotechnology company focused on developing innovative, proprietary therapies for treating different pathologies of “scarred cellular” senescence, including late-stage cancer and chronic diseases, today announced that it closed a $2.5 million seed financing round earlier in the year, led by Apollo Health Ventures, with participation from Curie Capital B.V., ROM Utrecht Region and Longevity Tech Fund. The proceeds will be used to progress Cleara’s compounds toward clinical development and further build the Company’s developmental pipeline and management team.

Quick answer

CLEARA Biotech B.V raised $2.5 Million in a Seed round, dated September 28, 2022. CLEARA Biotech B.V is based in Utrecht, Utrecht, Netherlands.

How much did CLEARA Biotech B.V raise?
CLEARA Biotech B.V raised $2.5 Million in a Seed round on September 28, 2022.
What does CLEARA Biotech B.V do?
Cleara is a biopharmaceutical R&D company dedicated to discovery and development of therapies against cancer and chronic diseases through selective elimination of subtypes of cellular senescence.
Where is CLEARA Biotech B.V based and how big is it?
CLEARA Biotech B.V is based in Utrecht, Utrecht, Netherlands.

Source: Fundz verified event record.

Who to call at CLEARA Biotech B.V, and when

A new round usually means CLEARA Biotech B.V is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CLEARA Biotech B.V raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CLEARA Biotech B.V, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CLEARA Biotech B.V. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CLEARA Biotech B.V

Location

Utrecht, Utrecht, Netherlands

About

Cleara is a biopharmaceutical R&D company dedicated to discovery and development of therapies against cancer and chronic diseases through selective elimination of subtypes of cellular senescence. Through detailed understanding of the molecular and biological pathways that underlie these individual pathological phenotypes, we set up disruptive, innovative and proprietary platform technology to design and optimize (peptide-based) therapeutics that exploit their weak spots for safe and selective clearance. Cleara’s lead FOXO4 program is focused on generation of disruptive and proprietary technology against “scarred” cellular senescence for treatment of metastatic, mutant-p53 cancer. Senescent cells are associated with a range of chronic diseases and cancer progression. However, Cleara acknowledges that there are different kinds of senescence. We do not focus on “magic bullets” to kill all senescent cells but develop specific and safe compounds against unique subtypes. Cleara’s goal is to progress these into clinical development with the intent of precision medicine against specific diseases with clear niche-directed anti-senescence lead candidates, with associated biomarkers, around its FOXO4-based D-amino acid pipeline.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CLEARA Biotech B.V raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for CLEARA Biotech B.V's next move

See what Strategic adds

CLEARA Biotech B.V raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.